Can Oral Procyanidin Supplements Strengthen Existing Hair and Prevent Shedding?

Hair shedding is a universal experience, but for some, it becomes a distressing condition that affects confidence and self-image. In the search for gentler, plant-based approaches to hair maintenance, procyanidin supplements—derived from fruits such as apples, grapes, and cocoa—have emerged as a topic of growing interest.

Procyanidins are polyphenolic compounds known for their antioxidant capacity and potential biological effects on skin and hair. Yet, the question remains: can taking them orally truly strengthen existing hair and prevent excessive shedding?

How Procyanidins Might Influence Hair Growth

To understand their potential, it is necessary to explore the hair growth cycle. Hair follicles alternate between three phases: anagen (growth), catagen (regression), and telogen (resting/shedding). Hair thinning or loss often occurs when follicles prematurely enter catagen or telogen, shortening the growth period. Laboratory studies suggest that certain types of procyanidins—particularly procyanidin B2—might help maintain follicles in the anagen phase, thus promoting growth and reducing shedding.

The proposed mechanisms are multifaceted. Procyanidin B2 appears to stimulate keratinocyte proliferation (cells responsible for producing keratin, the main structural protein of hair), enhance vascular endothelial growth factor (VEGF) expression, and suppress 5α-reductase, an enzyme that converts testosterone to dihydrotestosterone (DHT)—a hormone strongly linked to androgenetic alopecia. These effects were observed in preclinical models, suggesting a plausible biological basis for its role in hair health.

The Evidence: From Laboratory to Human Trials

Research examining procyanidins in hair biology began with topical applications, later expanding to oral formulations. However, while both routes share mechanistic similarities, the oral pathway introduces additional questions regarding absorption, bioavailability, and systemic metabolism.

A pivotal animal study conducted by Lee et al. (2022) investigated the oral administration of Annurca apple extract, rich in procyanidin B2, in C57BL/6 mice over 21 days. The treated mice displayed visibly thicker and longer hair, alongside increased hair weight and density. Molecular analysis revealed elevated expression of VEGFA and FGF-7 (fibroblast growth factor 7), both key markers of follicular growth.

Notably, 5α-reductase expression decreased, implying potential anti-androgenic effects. Histological evaluation confirmed enhanced keratin protein expression within follicles. Despite these promising findings, this model has clear limitations: murine hair cycles differ from human cycles, and short-term responses do not necessarily predict sustained effects in humans (Lee et al., 2022).

Human trials, although fewer, have provided some encouraging yet preliminary results. A randomized, placebo-controlled study led by Tenore et al. (2018) evaluated the effects of an Annurca apple nutraceutical formulation administered orally for two months in healthy adults with mild hair thinning. **Participants showed significant increases in hair density, keratin content, and perceived hair quality compared to placebo. **

In vitro experiments conducted alongside the trial confirmed increased keratin expression in cultured human keratinocytes. However, the study had limitations: a short duration, a modest sample size, and lack of diversity among participants. These constraints prevent generalization of the findings beyond the studied cohort (Tenore et al., 2018).

A 2022 review by Ring and colleagues assessed available nutraceutical interventions for androgenetic alopecia. The authors noted that while procyanidin-based supplements appear safe and modestly effective, the existing trials lack the statistical power, duration, and standardization necessary for conclusive claims. They emphasized that supplements operate under far looser regulatory oversight than approved pharmaceuticals, making their efficacy data inherently variable and often difficult to compare (Ring et al., 2022).

Further clinical evidence, such as the double-blind, placebo-controlled trial conducted by Yeniay and Arca (2022) using topical procyanidin B2, reinforces the compound’s mechanistic potential.

After 16 weeks, men with androgenetic alopecia exhibited significant increases in hair count and anagen/telogen ratio. Although topical rather than oral, these results strengthen the biological plausibility of procyanidin’s effects on follicular dynamics. Still, differences in absorption pathways mean oral efficacy cannot be inferred directly from topical success (Yeniay & Arca, 2022).

A Critical Perspective on Oral Supplementation

When assessing whether oral procyanidin supplements can truly strengthen hair and prevent shedding, the evidence must be weighed carefully. While preclinical and small human trials point toward potential benefits, these findings are far from definitive. Bioavailability remains a key question: polyphenolic compounds are known for their limited absorption and rapid metabolism, which could reduce their systemic efficacy. Moreover, the heterogeneity of commercial products complicates interpretation, as not all supplements contain standardized concentrations of active procyanidins.

The broader scientific consensus suggests that while oral procyanidins might provide some supportive effects on hair quality and strength, they should not yet be viewed as proven therapeutic agents. Their impact, if present, is likely modest and dependent on individual variables such as diet, hormonal status, and overall health. In contrast, pharmaceutical interventions like finasteride and minoxidil have undergone extensive, long-term clinical testing and remain the only FDA-approved options for androgenetic alopecia.

Conclusion

Current research indicates that oral procyanidin supplementation has biological plausibility and early evidence suggesting benefits for hair growth and strength. However, the data are not yet robust enough to confirm its clinical effectiveness. For individuals experiencing shedding or hair weakness, these supplements may offer a mild adjunctive benefit, but expectations should remain realistic. Larger, long-term, and standardized trials are needed to establish whether oral procyanidin truly represents a viable approach for maintaining existing hair and preventing loss.

References

Lee, Y. I., Ham, S., Lee, S. G., Jung, I., Suk, J., Yoo, J., Choi, S.-Y., & Lee, J. H. (2022). An exploratory in vivo study on the effect of Annurca apple extract on hair growth in mice. Current Issues in Molecular Biology, 44(12), 6280–6289. Retrieved from https://www.mdpi.com/1467-3045/44/12/428

Tenore, G. C., Caruso, D., Buonomo, G., D'Avino, M., Campiglia, P., Marinelli, L., & Novellino, E. (2018). Annurca apple nutraceutical formulation enhances keratin expression in a human model of skin and promotes hair growth and tropism in a randomized clinical trial. Journal of Medicinal Food, 21(1), 90–103. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775114

Ring, C., Karan, M., & Jackson, A. (2022). Nutraceuticals for androgenetic alopecia: A review of the evidence. International Journal of Trichology, 14(4), 139–148. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944288/

Yeniay, Y., & Arca, E. (2022). Evaluation of the efficacy and safety of topical procyanidin B2 in male androgenetic alopecia: A randomized, double-blind, placebo-controlled study. Turkish Journal of Dermatology, 16(2), 108–113. Retrieved from https://turkjdermatol.com/pdf/337910e4-2271-4883-88bd-db7abaf5adda/articles/tjd.tjd_41_22/TDD-16-108-En.pdf